Is OLMA undervalued or overvalued?
As of 2025-03-25, the Intrinsic Value of Olema Pharmaceuticals Inc (OLMA) is -8.98 USD. This OLMA valuation is based on the model Peter Lynch Fair Value. With the current market price of 4.23 USD, the upside of Olema Pharmaceuticals Inc is -312.22%. This means that OLMA is overvalued by 312.22%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -8.98 - -8.98 | -8.98 | -312.22% |
| P/E | (56.41) - (88.15) | (68.40) | -1717.1% |
| DDM - Stable | (9.52) - (25.17) | (17.35) | -510.1% |
| DDM - Multi | (6.54) - (13.86) | (8.93) | -311.0% |
| Market Cap (mil) | 289.04 |
| Beta | 1.66 |
| Outstanding shares (mil) | 68.33 |
| Enterprise Value (mil) | 253.15 |
| Market risk premium | 4.60% |
| Cost of Equity | 13.81% |
| Cost of Debt | 5.00% |
| WACC | 8.74% |